Botanical species · safety record

Drimia indica

The EFSA Compendium of Botanicals holds 8 constituent measurements for Drimia indica. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Drimia indica (Roxb.) Jessop

8Constituent measurements

0Safety records

4Cited sources

0Licensed products (Canada)

Also recorded as

Urginea indica (Roxb.) Kunth

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Alkaloids	Bulb / clove	Solvent extraction	—	Unspecified	Resolve DOI
Coumarins	Bulb / clove	Solvent extraction	—	Unspecified	Resolve DOI
Tannins	Bulb / clove	Solvent extraction	—	Unspecified	Resolve DOI
Anthraquinones	Bulb / clove	Solvent extraction	—	Unspecified	No resolvable identifier
Bufadienolides	Bulb / clove	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	No resolvable identifier
Cardiac glycosides	Bulb / clove	Solvent extraction	—	Unspecified	No resolvable identifier
Saponins	Bulb / clove	Solvent extraction	—	Unspecified	No resolvable identifier
Scillaren a	Unspecified	—	—	Chromatographic tests	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Hemalata, S. K., Shiva, Kameshwari M. N. Phytochemical studies in Urginea indica, (kunth) hyacinthaceae. World journal of pharmaceutical research, 2016, vol. 5, no. 8, p. 1130-1142.
Abbas, Saima., Bashir, Samra., Khan, Aslam., Mehmood, Malik Hassan., Gilani, Anwarul Hassan. Gastrointestinal Stimulant Effect of Urginea indica Kunth. and Involvement of Muscarinic Receptors . Phytotherapy research, 2012, vol. 26, no. 5, p. 704-708. DOI
Jain, Satyendra Kumar., Dobhal, Sonal., Dobhal, Mahabeer Prasad. Isolation and characterization of new bufadienolides from Urginea indica. Chemical science review and letters, 2014, vol. 3, no. 11), 608-61, p. 7 pp.
Rangaswami, S., Subramanian, S. Sankara. Identity of the crystalline glycoside of Urginea indica with scillaren A. Journal of scientific & industrial research, 1956, vol. 15C, p. 80-1.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature